Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Windtree Therapeutics ( (WINT) ) is now available.
The Company has been actively engaging in financial maneuvers, including entering into a Common Stock Purchase Agreement allowing for periodic sales of common stock, and executing private placement transactions that resulted in the sale of over 27 million shares. This activity, supported by effective SEC registration statements, has significantly increased the company’s common stock from approximately 592 thousand shares to over 1.6 million shares within a few months. The company also converted preferred shares into common stock and redeemed preferred shares, reshaping its financial structure and assets.
Learn more about WINT stock on TipRanks’ Stock Analysis page.